4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-25-009067
Options or other derivatives
- Chief Executive Officer acquired 414,015 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Owen Adams Catherine Chief Executive Officer | 2025-03-24 | Grant or award · Stock Option (Right to Buy) | +319,976 | 319,976 | D | ||
| Owen Adams Catherine Chief Executive Officer | 2025-03-24 | Grant or award · Restricted Stock Units | +94,039 | 94,039 | D | ||
Loading xslF345X05/form4-03262025_110347.xml…